UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q4 2022 | 2023-02-09 | Future report Set alerts | |
| Q3 2022 | 2022-10-27 | 0.28 | 0.28 |
| Q2 2022 | 2022-07-28 | 0.17 | 0.17 |
| Q1 2022 | 2022-04-28 | 0.08 | 0.08 |
| Q4 2021 | 2022-02-10 | 0.17 | 0.17 |
| Q3 2021 | 2021-10-28 | 0.22 | 0.22 |
| Q2 2021 | 2021-07-29 | 0.19 | 0.19 |
| Q1 2021 | 2021-04-29 | 0.08 | 0.08 |
| Q4 2020 | 2021-02-11 | 0.23 | 0.23 |
| Q3 2020 | 2020-10-27 | 0.24 | 0.24 |
| 2016-06-20 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2016-06-15 | Reiterated Rating | Wedbush | Outperform | $112.00 |
| 2016-05-16 | Reiterated Rating | Robert W. Baird | Hold | |
| 2016-04-28 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-04-28 | Reiterated Rating | Oppenheimer | Hold | |
| 2016-04-28 | Reiterated Rating | Oppenheimer Holdings Inc. | Hold | |
| 2016-04-14 | Initiated Coverage | BTIG Research | Buy | $80.00 |
| 2016-02-26 | Lower Price Target | Raymond James | Outperform | $100.00 to $81.00 |
| 2016-02-26 | Lower Price Target | Leerink Swann | $100.00 to $90.00 | |
| 2016-02-26 | Lower Price Target | Raymond James Financial Inc. | Outperform | $100.00 to $81.00 |
| 2016-02-24 | Boost Price Target | Benchmark Co. | Buy | $86.00 to $105.00 |
| 2016-02-24 | Lower Price Target | Canaccord Genuity | Buy | $100.00 to $81.00 |
| 2016-02-24 | Reiterated Rating | Wedbush | Outperform | $112.00 |
| 2016-02-24 | Boost Price Target | Jefferies Group | Buy | $90.00 to $100.00 |
| 2016-02-24 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $120.00 to $100.00 |
| 2016-02-09 | Reiterated Rating | Piper Jaffray | Buy | |
| 2016-02-09 | Reiterated Rating | Piper Jaffray Cos. | Buy | |
| 2016-02-08 | Downgrade | Robert W. Baird | Outperform to Neutral | $100.00 to $74.00 |
| 2016-01-12 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2015-11-05 | Reiterated Rating | Piper Jaffray | In-Line to Buy | $103.00 to $107.00 |
| 2015-11-05 | Reiterated Rating | Canaccord Genuity | Buy | $100.00 |
| 2015-11-02 | Initiated Coverage | Morgan Stanley | Overweight | $106.00 |
| 2015-10-15 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2015-10-15 | Upgrade | Sterne Agee CRT | Neutral to Buy | $90.00 |
| 2015-10-15 | Upgrade | Leerink Swann | Market Perform to Outperform | $90.00 to $100.00 |
| 2015-09-21 | Reiterated Rating | William Blair | Outperform | |
| 2015-09-17 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $95.00 to $120.00 |
| 2015-09-09 | Reiterated Rating | William Blair | Outperform | |
| 2015-08-25 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2015-08-11 | Reiterated Rating | Leerink Swann | Positive | $90.00 |
| 2015-08-06 | Boost Price Target | Robert W. Baird | Outperform | $95.00 to $100.00 |
| 2015-08-06 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $70.00 to $95.00 |
| 2015-08-06 | Boost Price Target | Jefferies Group | Buy | $80.00 to $98.00 |
| 2015-08-06 | Boost Price Target | Canaccord Genuity | Buy | $69.00 to $95.00 |
| 2015-08-06 | Reiterated Rating | Piper Jaffray | Buy | $103.00 |
| 2015-07-18 | Boost Price Target | Cowen and Company | $80.00 to $100.00 | |
| 2015-07-08 | Initiated Coverage | Robert W. Baird | Outperform | $95.00 |
| 2015-05-09 | Reiterated Rating | Jefferies Group | Buy | $73.00 to $80.00 |
| 2015-05-07 | Reiterated Rating | Cowen and Company | Outperform | $70.00 to $80.00 |
| 2015-04-30 | Reiterated Rating | Canaccord Genuity | Buy | $69.00 |
| 2015-04-30 | Boost Price Target | Oppenheimer | Market Perform | $64.00 to $69.00 |
| 2015-04-20 | Boost Price Target | Wedbush | Buy | $73.00 to $80.00 |
| 2015-04-14 | Set Price Target | Canaccord Genuity | Buy | $69.00 |
| 2015-02-26 | Set Price Target | Canaccord Genuity | Buy | $69.00 |
| 2015-02-26 | Set Price Target | Wedbush | Buy | $73.00 |
| 2015-02-26 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $60.00 to $70.00 |
| 2015-02-26 | Boost Price Target | Jefferies Group | Buy | $60.00 to $73.00 |
| 2015-01-27 | Boost Price Target | Oppenheimer | Market Perform | $47.00 to $64.00 |
| 2015-01-26 | Set Price Target | Wedbush | Buy | $70.00 |
| 2015-01-26 | Set Price Target | Canaccord Genuity | Buy | $69.00 |
| 2015-01-06 | Downgrade | Sterne Agee CRT | Buy to Neutral | $56.00 |
| 2014-12-29 | Set Price Target | Benchmark Co. | Buy | $57.00 to $69.00 |
| 2014-12-17 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $54.00 to $60.00 |
| 2014-12-08 | Initiated Coverage | Cowen and Company | Outperform | $65.00 |
| 2014-11-07 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $46.00 to $54.00 |
| 2014-11-04 | Initiated Coverage | Northcoast Research | Buy | |
| 2014-08-07 | Reiterated Rating | Raymond James | Outperform | $44.00 to $46.00 |
| 2014-08-07 | Boost Price Target | Canaccord Genuity | Buy | $40.00 to $48.00 |
| 2014-06-17 | Boost Price Target | Canaccord Genuity | Buy | $38.00 to $40.00 |
| 2014-05-02 | Reiterated Rating | Raymond James | Outperform | $44.00 |
| 2014-05-02 | Reiterated Rating | Leerink Swann | Market Perform | $33.00 |
| 2014-04-28 | Upgrade | Ned Davis Research | Sell to Neutral | |
| 2014-04-10 | Upgrade | Sterne Agee CRT | Neutral to Buy | $50.00 |
| 2014-03-21 | Initiated Coverage | Sterne Agee CRT | Neutral | $50.00 |
| 2014-03-20 | Initiated Coverage | Sterne Agee CRT | Neutral | $50.00 |
| 2014-02-21 | Boost Price Target | Jefferies Group | Buy | $40.00 to $50.00 |
| 2014-02-20 | Downgrade | Feltl & Co. | Hold to Sell | |
| 2014-01-24 | Boost Price Target | Canaccord Genuity | Buy | $34.00 to $44.00 |
| 2014-01-14 | Reiterated | The Benchmark Company | Buy | $40 to $44 |
| 2014-01-14 | Boost Price Target | Benchmark Co. | Buy | $40.00 to $44.00 |
| 2013-11-07 | Upgrade | Northland Capital | Under Perform to Market Perform | |
| 2013-11-07 | Boost Price Target | Raymond James | Outperform | $31.00 to $34.00 |
| 2013-11-07 | Reiterated Rating | JPMorgan Chase & Co. | Buy | $32.00 |
| 2013-11-07 | Boost Price Target | Wedbush | Outperform | $39.00 |
| 2013-11-07 | Boost Price Target | Jefferies Group | Buy | $27.00 to $40.00 |
| 2013-11-07 | Boost Price Target | Canaccord Genuity | Buy | $26.00 to $34.00 |
| 2013-11-07 | Boost Price Target | Benchmark Co. | Buy | $37.00 to $40.00 |
| 2013-11-07 | Upgrade | Feltl & Co. | Sell to Hold | |
| 2013-11-07 | Upgrade | Northland Securities | Underperform to Market Perform | $18.00 to $30.00 |
| 2013-10-15 | Initiated | The Benchmark Company | Buy | $37 |
| 2013-10-15 | Initiated Coverage | Benchmark Co. | Buy | $37.00 |
| 2013-10-14 | Reiterated Rating | Wedbush | Buy | $31.00 |
| 2013-10-14 | Boost Price Target | Raymond James | Outperform | $26.00 to $31.00 |
| 2013-08-12 | Reiterated | Feltl & Co. | Sell | $16.50 to $18.25 |
| 2013-08-08 | Reiterated | Canaccord Genuity | Buy | $25 to $26 |
| 2013-07-24 | Downgrade | Northland Capital | Outperform to Under Perform | $17 |
| 2013-06-13 | Downgrade | Feltl & Co. | Hold to Sell | |
| 2013-03-13 | Reiterated | Wunderlich | Buy | $18 to $20 |
| 2013-02-25 | Reiterated | Feltl & Co. | Hold | $14 to $15.50 |
| 2013-01-14 | Reiterated | Wunderlich | Buy | $15 to $18 |
| 2012-01-17 | Initiated | Brean Murray | Buy | $12.50 |
| 2012-01-11 | Downgrade | MLV & Co | Buy to Hold | $9 |
| 2011-12-29 | Initiated | Wunderlich | Buy | $12 |
| 2011-12-20 | Initiated | MLV & Co | Buy | $11 |
| 2011-10-28 | Downgrade | Feltl & Co. | Buy to Hold | |
| 2011-08-16 | Upgrade | Feltl & Co. | Hold to Buy | $15.85 to $15.35 |
| 2016-06-20 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2016-06-15 | Reiterated Rating | Wedbush | Outperform | $112.00 |
| 2016-05-16 | Reiterated Rating | Robert W. Baird | Hold | |
| 2016-04-28 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-04-28 | Reiterated Rating | Oppenheimer | Hold |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In DXCM 509 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Vanguard Group, Inc | 43.68M |
| BlackRock Inc. | 33.96M |
| BAILLIE GIFFORD & CO | 18.11M |
| SANDS CAPITAL MANAGEMENT, LLC | 16.69M |
| STATE STREET CORP | 16.39M |
| Capital Research Global Investors | 10.53M |
| JPMORGAN CHASE & CO | 10.25M |
| FMR LLC | 10.20M |
| WELLINGTON MANAGEMENT CO LLP | 9.05M |
| Nuveen Asset Management, LLC | 8.62M |
| GEODE CAPITAL MANAGEMENT, LLC | 8.02M |
| JENNISON ASSOCIATES LLC | 6.94M |
| Clearbridge Investments, LLC | 5.41M |
| HENDERSON GROUP PLC | 4.89M |
| VOYA INVESTMENT MANAGEMENT LLC | 4.45M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| SAYER KEVIN R President & COO | 0.44% (335171) | DXCM / |
| LORD JONATHAN T MD | 0.17% (126373) | BIOL / DXCM / MAKO / SRCL / |
| Pacelli Steven Robert EVP, Strategy & Corp. Dev. | 0.17% (125830) | DXCM / |
| Abbey Donald EVP Quality | 0.15% (109953) | CFN / DXCM / |
| Balo Andrew K SVP, Regulatory and Clinical | 0.14% (108567) | DXCM / |
| Blackford Quentin S. EVP, CFO, PFO & PAO | 0.14% (102258) | ATEC / DXCM / NUVA / |
| Leach Jacob Steven SVP, Research & Development | 0.13% (98878) | DXCM / |
| LISTER JOHN General Counsel, VP of HR | 0.11% (84034) | DXCM / |
| ACE HEATHER S SVP Human Resources | 0.10% (74232) | DXCM / VOLC / |
| MOY JEFFREY SVP, Operations | 0.09% (68511) | DXCM / |
| ALTMAN STEVEN R | 0.08% (58502) | DXCM / UBNT / |
| Murphy Patrick Michael VP, Legal Aff & Chf Compl Ofcr | 0.06% (46180) | DXCM / |
| AUGUSTINOS NICHOLAS | 0.04% (31015) | DXCM / |
| KAHN BARBARA | 0.03% (23095) | DXCM / |
| FOLETTA MARK G | 0.02% (13143) | AHS / AMBI / DXCM / RGLS / TOCA / |
| VALDES JORGE A CTO | 0.01% (10442) | DXCM / |
| DOUBLEDAY RICHARD Sr. VP. Worldwide Sales | 0.01% (8810) | DXCM / |
| ROPER JESS VP, CFO | 0.01% (8452) | DXCM / |
| Collins Richard Alexander | 0.01% (5855) | DXCM / |
| TOPOL ERIC | 0.01% (4653) | DXCM / VOLC / |
| SKYLER JAY S | 0.01% (4553) | DXCM / |
UM